Corcept Therapeutics (CORT) Other Non-Current Assets (2010 - 2026)
Corcept Therapeutics (CORT) posted Other Non-Current Assets of $2.9 million for Q2 2026, down 42.83% sequentially from $5.2 million in Q1 2026, and down 64.52% YoY from $8.3 million in Q2 2025.
Corcept Therapeutics (CORT) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Corcept Therapeutics has reported Other Non-Current Assets for 17 years, with the latest figure at $2.9 million in Q2 2026.
- Quarterly Other Non-Current Assets fell 64.52% year-over-year to $2.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.9 million (down 64.52% YoY) and the FY2025 annual result came in at $5.2 million, down 22.04% from the prior year.
- Other Non-Current Assets eased to $2.9 million in Q2 2026 per CORT's latest filing, from $5.2 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $8.3 million in Q2 2025 and troughed at $1.8 million in Q2 2022.
- A 5-year average of $5.6 million and a median of $5.8 million in 2024 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2023 and 2026: Other Non-Current Assets jumped 140.62% in 2023, then tumbled 64.52% in 2026.
- Over 5 years, Other Non-Current Assets stood at $5.1 million in 2022, then gained by 29.32% to $6.5 million in 2023, then advanced by 1.05% to $6.6 million in 2024, then dropped by 22.04% to $5.2 million in 2025, then slumped by 42.83% to $2.9 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $2.9 million, $5.2 million, and $5.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | 2.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.95 Mn |
| Mar 31, 2026 | 5.15 Mn |
| Dec 31, 2025 | 5.15 Mn |
| Sep 30, 2025 | 8.05 Mn |
| Jun 30, 2025 | 8.30 Mn |
| Mar 31, 2025 | 6.61 Mn |
| Dec 31, 2024 | 6.61 Mn |
| Sep 30, 2024 | 6.97 Mn |
| Jun 30, 2024 | 6.94 Mn |
| Mar 31, 2024 | 6.39 Mn |
| Dec 31, 2023 | 6.54 Mn |
| Sep 30, 2023 | 6.54 Mn |
| Jun 30, 2023 | 4.41 Mn |
| Mar 31, 2023 | 4.76 Mn |
| Dec 31, 2022 | 5.06 Mn |
| Sep 30, 2022 | 5.08 Mn |
| Jun 30, 2022 | 1.83 Mn |
| Mar 31, 2022 | 2.98 Mn |
| Dec 31, 2021 | 3.08 Mn |
| Sep 30, 2021 | 4.11 Mn |